JOHNSON & JOHNSON
- SEC CIK
- 0000200406
FATE holding history
FATE THERAPEUTICS INC
Every 13F filing in which JOHNSON & JOHNSON reported holding FATE, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
FATE overviewAll 13F holders of FATEFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 3,379,064 | $9.12M | 1.14% | 00.0% | Unchanged |
| Q1 2026 | 3,379,064 | $4.05M | 0.62% | 00.0% | Unchanged |
| Q4 2025 | 3,379,064 | $3.32M | 0.60% | 00.0% | Unchanged |
| Q3 2025 | 3,379,064 | $4.26M | 0.84% | 00.0% | Unchanged |
| Q2 2025 | 3,379,064 | $3.51M | 1.05% | 00.0% | Unchanged |
| Q1 2025 | 3,379,064 | $2.67M | 0.78% | 00.0% | Unchanged |
| Q4 2024 | 3,379,064 | $5.58M | 1.44% | 00.0% | Unchanged |
| Q3 2024 | 3,379,064 | $11.83M | 2.77% | 00.0% | Unchanged |
| Q2 2024 | 3,379,064 | $11.08M | 2.77% | 00.0% | Unchanged |
| Q1 2024 | 3,379,064 | $24.8M | 0.56% | 00.0% | Unchanged |
| Q4 2023 | 3,379,064 | $12.64M | 0.29% | 00.0% | Unchanged |
| Q3 2023 | 3,379,064 | $7.16M | 2.64% | 00.0% | Unchanged |
| Q2 2023 | 3,379,064 | $16.08M | 4.99% | 00.0% | Unchanged |
| Q1 2023 | 3,379,064 | $19.26M | 6.27% | 00.0% | Unchanged |
| Q4 2022 | 3,379,064 | $34.1M | 9.92% | 00.0% | Unchanged |
| Q3 2022 | 3,379,064 | $75.73M | 22.28% | 00.0% | Unchanged |
| Q2 2022 | 3,379,064 | $83.73M | 21.39% | 00.0% | Unchanged |
| Q1 2022 | 3,379,064 | $131.01M | 24.77% | 00.0% | Unchanged |
| Q4 2021 | 3,379,064 | $197.71M | 22.51% | 00.0% | Unchanged |
| Q3 2021 | 3,379,064 | $200.28M | 17.57% | +3,379,064 | New |